banner add

New Drug Approved for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

from NYT > Health https://ift.tt/MFGJ3z1
via IFTTT

No comments

A Loophole Brings Cystic Fibrosis Patients a ‘Miracle Drug’ in Generic Form

A generic version of a breakthrough cystic fibrosis drug, manufactured in Bangladesh for a fraction of the American price, may give some fam...

Theme images by PLAINVIEW. Powered by Blogger.